{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T22:12:14Z","timestamp":1790547134768,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100017183","name":"Janssen Scientific Affairs, LLC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017183","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s10461-020-02937-8","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T16:10:59Z","timestamp":1591114259000},"page":"3562-3573","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Antiretroviral Adherence, Drug Resistance, and the Impact of Social Determinants of Health in HIV-1 Patients in the US"],"prefix":"10.1007","volume":"24","author":[{"given":"C.","family":"Benson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. J.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mesana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Y.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,2]]},"reference":[{"key":"2937_CR1","unstructured":"CDC. Today\u2019s HIV\/AIDS epidemic. CDC fact sheet (2016)."},{"issue":"2","key":"2937_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1001\/jama.2016.8900","volume":"316","author":"HF Gunthard","year":"2016","unstructured":"Gunthard HF, Saag MS, Benson CA, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the international antiviral society-USA panel. JAMA. 2016;316(2):191\u201321010.","journal-title":"JAMA"},{"issue":"9","key":"2937_CR3","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1506816","volume":"373","author":"JD Lundgren","year":"2015","unstructured":"SSG Insight Start Study Group, Lundgren JD, Babiker AG, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795\u2013807.","journal-title":"N Engl J Med"},{"issue":"9","key":"2937_CR4","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1056\/NEJMoa1507198","volume":"373","author":"C Danel","year":"2015","unstructured":"Danel C, Moh R, Gabillard D, et al. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. The New England Journal of Medicine. 2015;373(9):808\u201322.","journal-title":"The New England Journal of Medicine"},{"key":"2937_CR5","unstructured":"UNAIDS. HIV Global Statistics. 2018. https:\/\/www.hiv.gov\/hiv-basics\/overview\/data-and-trends\/global-statistics."},{"issue":"1","key":"2937_CR6","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12939-017-0683-y","volume":"16","author":"TD Ritchwood","year":"2017","unstructured":"Ritchwood TD, Bishu KG, Egede LE. Trends in healthcare expenditure among people living with HIV\/AIDS in the United States: evidence from 10 years of nationally representative data. Int J Equity Health. 2017;16(1):188\u2013188.","journal-title":"Int J Equity Health"},{"key":"2937_CR7","unstructured":"U.S. Department of Health & Human Services. Statement on FY2020 budget proposal for ending the HIV epidemic in America 2019. https:\/\/www.hhs.gov\/about\/news\/2019\/03\/11\/statement-on-fy2020-budget-proposal-for-ending-the-hiv-epidemic-in-america.html."},{"key":"2937_CR8","unstructured":"HIV.gov. What is 'ending the HIV epidemic: a plan for America'? 2019. https:\/\/www.hiv.gov\/federal-response\/ending-the-hiv-epidemic\/overview."},{"key":"2937_CR9","unstructured":"National Center for HIV\/AIDS. Understanding the HIV care continuum. 2018. https:\/\/www.cdc.gov\/hiv\/pdf\/library\/factsheets\/cdc-hiv-care-continuum.pdf."},{"issue":"5","key":"2937_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1089\/apc.2016.0291","volume":"31","author":"D Onoya","year":"2017","unstructured":"Onoya D, Nattey C, Budgell E, et al. Predicting the need for third-line antiretroviral therapy by identifying patients at high risk for failing second-line antiretroviral therapy in South Africa. AIDS Patient Care STDs. 2017;31(5):205\u201312.","journal-title":"AIDS Patient Care STDs"},{"issue":"2","key":"2937_CR11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2174\/187152611795589663","volume":"11","author":"JB Nachega","year":"2011","unstructured":"Nachega JB, Marconi VC, van Zyl GU, et al. HIV treatment adherence, drug resistance, virologic failure: evolving concepts. Infect Disord Drug Targets. 2011;11(2):167\u201374.","journal-title":"Infect Disord Drug Targets"},{"issue":"Suppl 1","key":"2937_CR12","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.4081\/idr.2013.s1.e5","volume":"5","author":"PS Pennings","year":"2013","unstructured":"Pennings PS. HIV drug resistance: problems and perspectives. Infect Dis Rep. 2013;5(Suppl 1):e5.","journal-title":"Infect Dis Rep"},{"issue":"3","key":"2937_CR13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1089\/apc.2008.0162","volume":"23","author":"BJ Rudy","year":"2009","unstructured":"Rudy BJ, Murphy DA, Harris DR, Muenz L, Ellen J, Hivai ATN. Patient-related risks for nonadherence to antiretroviral therapy among HIV-infected youth in the United States: a study of prevalence and interactions. AIDS Patient Care STDS. 2009;23(3):185\u201394.","journal-title":"AIDS Patient Care STDS"},{"issue":"1","key":"2937_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/00042560-200101010-00012","volume":"26","author":"CA Kleeberger","year":"2001","unstructured":"Kleeberger CA, Phair JP, Strathdee SA, Detels R, Kingsley L, Jacobson LP. Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 2001;26(1):82\u201392.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2937_CR15","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/1471-2334-13-154","volume":"13","author":"HM Do","year":"2013","unstructured":"Do HM, Dunne MP, Kato M, Pham CV, Nguyen KV. Factors associated with suboptimal adherence to antiretroviral therapy in Viet Nam: a cross-sectional study using audio computer-assisted self-interview (ACASI). BMC Infect Dis. 2013;13:154.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2937_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1177\/1545109712467068","volume":"13","author":"G Poles","year":"2014","unstructured":"Poles G, Li M, Siril H, et al. Factors associated with different patterns of nonadherence to HIV care in Dar es Salaam, Tanzania. J Int Assoc Provid AIDS Care. 2014;13(1):78\u201384.","journal-title":"J Int Assoc Provid AIDS Care"},{"issue":"6","key":"2937_CR17","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1521\/aeap.2014.26.6.521","volume":"26","author":"L Beer","year":"2014","unstructured":"Beer L, Skarbinski J. Adherence to antiretroviral therapy among HIV-infected adults in the United States. AIDS Educ Prev. 2014;26(6):521\u201337.","journal-title":"AIDS Educ Prev"},{"key":"2937_CR18","unstructured":"EACS. European AIDS Clinical Society Guidelines 2017, 2017."},{"key":"2937_CR19","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3389\/fphar.2017.00831","volume":"8","author":"SA Iacob","year":"2017","unstructured":"Iacob SA, Iacob DG, Jugulete G. Improving the adherence to antiretroviral therapy, a difficult but essential task for a successful HIV treatment-clinical points of view and practical considerations. Front Pharmacol. 2017;8:831.","journal-title":"Front Pharmacol"},{"key":"2937_CR20","unstructured":"Lafeuille MH, Woodruff K, Dunn K, et al. Adherence to antiretrovirals (ARVs) in medicaid-insured patients living with human immunodeficiency virus (HIV). Presented at the Academy of Managed Care Pharmacy (AMCP) managed care & specialty pharmacy annual meeting, March 27\u201330, 2017, Denver, Colorado."},{"issue":"Suppl 1","key":"2937_CR21","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1093\/ofid\/ofv133.291","volume":"2","author":"J Forlenza","year":"2015","unstructured":"Forlenza J, Brown K, Shprecher A, et al. An evaluation of patient characteristics, duration on antiretrovirals (ARVs) and adherence in a large, insured United States population receiving HIV treatment between 2010 and 2014. Open Forum Infect Dis. 2015;2(Suppl 1):416.","journal-title":"Open Forum Infect Dis"},{"key":"2937_CR22","unstructured":"McClung RP, Saduvala N, Oster AM, Heneine W, Johnson JA, Hernandez AL. Integrase and other transmitted HIV drug resistance: 23 US jurisdictions, 2013\u20132016, March 4\u20137, 2019, Seattle, Washington."},{"issue":"1","key":"2937_CR23","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1038\/s41598-018-21081-x","volume":"8","author":"J Kim","year":"2018","unstructured":"Kim J, Lee E, Park BJ, Bang JH, Lee JY. Adherence to antiretroviral therapy and factors affecting low medication adherence among incident HIV-infected individuals during 2009\u20132016: a nationwide study. Sci Rep. 2018;8(1):3133.","journal-title":"Sci Rep"},{"issue":"7","key":"2937_CR24","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1080\/09540121.2016.1271389","volume":"29","author":"B Rachlis","year":"2017","unstructured":"Rachlis B, Burchell AN, Gardner S, et al. Social determinants of health and retention in HIV care in a clinical cohort in Ontario, Canada. AIDS Care. 2017;29(7):828\u201337.","journal-title":"AIDS Care"},{"issue":"1","key":"2937_CR25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13104-019-4204-5","volume":"12","author":"MA Morowatisharifabad","year":"2019","unstructured":"Morowatisharifabad MA, Movahed E, Farokhzadian J, et al. Antiretroviral therapy adherence and its determinant factors among people living with HIV\/AIDS: a case study in Iran. BMC Res Notes. 2019;12(1):162.","journal-title":"BMC Res Notes"},{"issue":"8","key":"2937_CR26","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1080\/09540121.2019.1612022","volume":"31","author":"ELP Bradley","year":"2019","unstructured":"Bradley ELP, Frazier EL, Carree T, Hubbard McCree D, Sutton MY. Psychological and social determinants of health, antiretroviral therapy (ART) adherence, and viral suppression among HIV-positive black women in care. AIDS Care. 2019;31(8):932\u201341.","journal-title":"AIDS Care"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-020-02937-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-020-02937-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-020-02937-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T20:28:51Z","timestamp":1622579331000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-020-02937-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,2]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2937"],"URL":"https:\/\/doi.org\/10.1007\/s10461-020-02937-8","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,2]]},"assertion":[{"value":"2 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"C. Benson, K.J. Dunn, E.Y. Wong, W. Chow, H. Hardy, J. Song, and K. Brown are employees of Janssen and may be stockholders in Johnson & Johnson.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}